Skip to main content
Fig. 4 | Critical Care

Fig. 4

From: A randomized controlled trial to determine whether beta-hydroxy-beta-methylbutyrate and/or eicosapentaenoic acid improves diaphragm and quadriceps strength in critically Ill mechanically ventilated patients

Fig. 4

Prescribed protein intakes, actual delivered protein intakes, and protein/kg/day are presented for the four experimental groups. The prescribed protein intake in grams was 94 (95% CI 85–103), 78 (95% CI 65–91), 87 (95% CI 76–98), and 78 (95% CI 69–87), respectively for Control, EPA, HMB, and HMB + EPA groups (p = 0.086). The mean protein intake in grams was 78 (95% CI 68–88), 68 (95% CI 55–81), 76 (95% CI 65–87), and 66 (95% CI 57–75), respectively for Control, EPA, HMB, and HMB + EPA groups (p = 0.276). The mean protein intake in Gm/Kg was 0.96 (95% CI 0.84–1.08), 0.78 (95% CI 0.62–0.94), 0.86 (95% CI 0.69–1.03), and 0.92 (95% CI 0.75–1.09), respectively for Control, EPA, HMB, and HMB + EPA groups (p = 0.373). As a result, there were no significant differences in protein intake (Kcal/Day) or protein intake normalized to body weight (Kcal/Kg) between the four groups

Back to article page